报价延迟最少15分钟:2025/09/12 04:15 EDT
盘前时段
|
||||
|
-- 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.25
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-18.66/-0.99
|
|
企业价值
45.12M
|
| 资产负债 |
|
每股账面净值
3.77
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
299.23K
|
|
每股收益
--
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/09/12 04:15 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies. |
